ELI LILLY & Co — Director's Dealing 2021

Sep 7, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2021-09-05

Reporting Person: Van Naarden Jacob (SVP, CEO LoxoONC, Pres LlyONC)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4692	Direct
Common Stock	4342	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit	$	2023-02-16	Common Stock (2785.0)		Direct
Restricted Stock Unit	$	2022-02-16	Common Stock (5461.0)		Direct

Footnotes

F1: The reported securities are held in a spousal lifetime access trust, of which the Reporting Person's wife is the trustee and the Reporting Person's wife and child are beneficiaries. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.